{{Rsnum
|rsid=352038
|Gene=PPBPP2
|Chromosome=4
|position=74052981
|Orientation=plus
|GMAF=0.0854
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 0.0 | 1.8 | 98.2
| HCB | 3.0 | 27.8 | 69.2
| JPT | 1.8 | 25.7 | 72.5
| YRI | 3.4 | 25.2 | 71.4
| ASW | 0.0 | 19.3 | 80.7
| CHB | 3.0 | 27.8 | 69.2
| CHD | 3.8 | 22.6 | 73.6
| GIH | 0.0 | 7.0 | 93.0
| LWK | 3.7 | 25.0 | 71.3
| MEX | 1.7 | 8.6 | 89.7
| MKK | 1.3 | 20.9 | 77.8
| TSI | 0.0 | 1.0 | 99.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=23221126
|Title=Polymorphisms in inflammation pathway genes and endometrial cancer risk
|OA=1
}}

{{PMID Auto
|PMID=17903303
|Title=Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}